Financhill
Back

Regeneron Pharmaceuticals, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
59

REGN
Regeneron Pharmaceuticals, Inc.

Last Price:
$767.87
Seasonality Move:
12.13%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REGN is experiencing buying pressure, which is a positive indicator for future bullish movement.

Regeneron Pharmaceuticals, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 747.47 Buy
20-day SMA: 745.1 Buy
50-day SMA: 678.03 Buy
200-day SMA: 600.91 Buy
8-day EMA: 400.86 Buy
20-day EMA: 196.11 Buy
50-day EMA: 85.47 Buy
200-day EMA: 22.33 Buy

Regeneron Pharmaceuticals, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 142.35 Buy
Relative Strength Index (14 RSI): 64.22 Buy
Chaikin Money Flow: 1264020 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (712.01 - 765.19) Buy
Bollinger Bands (100): (552.57 - 698.59) Buy

Regeneron Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Regeneron Pharmaceuticals, Inc. Stock

Is Regeneron Pharmaceuticals, Inc. Stock a Buy?

REGN Technical Analysis vs Fundamental Analysis

Buy
59
Regeneron Pharmaceuticals, Inc. (REGN) is a Buy

Is Regeneron Pharmaceuticals, Inc. a Buy or a Sell?

Regeneron Pharmaceuticals, Inc. Stock Info

Market Cap:
80.7B
Price in USD:
767.96
Share Volume:
2.3M

Regeneron Pharmaceuticals, Inc. 52-Week Range

52-Week High:
790.98
52-Week Low:
476.49
Buy
59
Regeneron Pharmaceuticals, Inc. (REGN) is a Buy

Regeneron Pharmaceuticals, Inc. Share Price Forecast

Is Regeneron Pharmaceuticals, Inc. Stock a Buy?

Fundamental Analysis of Regeneron Pharmaceuticals, Inc.

Is Regeneron Pharmaceuticals, Inc. a good investment?

  • Analysts estimate an earnings decrease this quarter of $3.81 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.74 per share, and an increase next year of $0.97 per share.

Technical Analysis of Regeneron Pharmaceuticals, Inc.

Should I short Regeneron Pharmaceuticals, Inc. stock?

* Regeneron Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.